BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18190609)

  • 1. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.
    Lee CS; Hu CY; Tsai HF; Wu CS; Hsieh SL; Liu LC; Hsu PN
    Clin Exp Immunol; 2008 Mar; 151(3):383-90. PubMed ID: 18190609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation.
    Chokdeemeeboon C; Ammarinthnukrowh P; Tongkobpetch S; Srichomtong C; Deekajorndech T; Rianthavorn P; Kingwattanakul P; Avihingsanon Y; Wright HL; Akkahat P; Hoven VP; Mekboonsonglarp W; Edwards SW; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    J Rheumatol; 2013 Aug; 40(8):1316-26. PubMed ID: 23729807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
    Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
    Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
    Han B; Moore PA; Wu J; Luo H
    Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.
    Huang ZM; Kang JK; Chen CY; Tseng TH; Chang CW; Chang YC; Tai SK; Hsieh SL; Leu CM
    J Immunol; 2012 Jun; 188(12):5867-76. PubMed ID: 22581854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
    Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
    Cheng CP; Sytwu HK; Chang DM
    J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death.
    Suárez-Fueyo A; Barber DF; Martínez-Ara J; Zea-Mendoza AC; Carrera AC
    J Immunol; 2011 Sep; 187(5):2376-85. PubMed ID: 21810603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.
    Otsuki T; Tomokuni A; Sakaguchi H; Aikoh T; Matsuki T; Isozaki Y; Hyodoh F; Ueki H; Kusaka M; Kita S; Ueki A
    Clin Exp Immunol; 2000 Feb; 119(2):323-7. PubMed ID: 10632670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
    Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
    J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
    J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
    Lin WW; Hsieh SL
    Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
    Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.